We attempted to send a notification to your email address but we were unable to verify that you provided a valid email address.
Please visit my profile to update your email address if you wish to receive notifications.
Otherwise, disable notifications and hide this message.
Your session was unable to be renewed and will be expiring in 0 seconds.
Click here to attempt to renew your session.
Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting
![[Loading...]](https://media-sixrivers.mynews360.com/images/loading.gif "Loading...")
